Literature DB >> 16930543

Identification and characterization of two mature isoforms of retinoschisin in murine retina.

Camasamudram Vijayasarathy1, Mary Ann Gawinowicz, Yong Zeng, Yuichiro Takada, Ronald A Bush, Paul A Sieving.   

Abstract

Retinoschisin (RS) is a 24 kDa secreted protein expressed in retina and is required for the structural and functional integrity of the retina. RS has been predicted to serve as an adhesive protein but the precise molecular mechanism by which it functions in retina is not yet known. During investigations on structural and functional aspects of RS in murine retina using proteomic tools, we identified two isoforms of RS that differed in mass by 200 Da with no apparent change in charge. Mass spectra and amino acid sequence analysis of the tryptic peptides revealed that these isoforms differed by two amino acids at the N-terminus which suggested processing of RS signal sequence at two cleavage sites by signal peptidase as the basic mechanism underlying the occurrence of two mature RS isoforms in retina. Bioinformatic analysis identified two potential cleavage sites (between amino acids 21-22 and 23-24) in RS signal sequence. The flexibility of the signal peptidase to cleave at two sites is correlated to the amino acid composition of the RS signal sequence. This finding represents a rare example of a naturally occurring signal sequence cleavage at more than one site in vivo.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16930543      PMCID: PMC1852445          DOI: 10.1016/j.bbrc.2006.07.202

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  24 in total

1.  High resolution two-dimensional electrophoresis of proteins.

Authors:  P H O'Farrell
Journal:  J Biol Chem       Date:  1975-05-25       Impact factor: 5.157

2.  Positional cloning of the gene associated with X-linked juvenile retinoschisis.

Authors:  C G Sauer; A Gehrig; R Warneke-Wittstock; A Marquardt; C C Ewing; A Gibson; B Lorenz; B Jurklies; B H Weber
Journal:  Nat Genet       Date:  1997-10       Impact factor: 38.330

3.  GOR method for predicting protein secondary structure from amino acid sequence.

Authors:  J Garnier; J F Gibrat; B Robson
Journal:  Methods Enzymol       Date:  1996       Impact factor: 1.600

4.  Substrate specificity of eukaryotic signal peptidase. Site-saturation mutagenesis at position -1 regulates cleavage between multiple sites in human pre (delta pro) apolipoprotein A-II.

Authors:  R J Folz; S F Nothwehr; J I Gordon
Journal:  J Biol Chem       Date:  1988-02-05       Impact factor: 5.157

5.  A new method for predicting signal sequence cleavage sites.

Authors:  G von Heijne
Journal:  Nucleic Acids Res       Date:  1986-06-11       Impact factor: 16.971

6.  How signal sequences maintain cleavage specificity.

Authors:  G von Heijne
Journal:  J Mol Biol       Date:  1984-02-25       Impact factor: 5.469

7.  Eukaryotic signal peptide structure/function relationships. Identification of conformational features which influence the site and efficiency of co-translational proteolytic processing by site-directed mutagenesis of human pre(delta pro)apolipoprotein A-II.

Authors:  S F Nothwehr; J I Gordon
Journal:  J Biol Chem       Date:  1989-03-05       Impact factor: 5.157

8.  Wild type and mutant signal peptides of Escherichia coli outer membrane lipoprotein interact with equal efficiency with mammalian signal recognition particle.

Authors:  P D Garcia; J Ghrayeb; M Inouye; P Walter
Journal:  J Biol Chem       Date:  1987-07-15       Impact factor: 5.157

9.  Transfer of proteins across membranes. I. Presence of proteolytically processed and unprocessed nascent immunoglobulin light chains on membrane-bound ribosomes of murine myeloma.

Authors:  G Blobel; B Dobberstein
Journal:  J Cell Biol       Date:  1975-12       Impact factor: 10.539

10.  Functional implications of the spectrum of mutations found in 234 cases with X-linked juvenile retinoschisis. The Retinoschisis Consortium.

Authors: 
Journal:  Hum Mol Genet       Date:  1998-07       Impact factor: 6.150

View more
  7 in total

1.  Retinoschisin (RS1) interacts with negatively charged lipid bilayers in the presence of Ca2+: an atomic force microscopy study.

Authors:  Svetlana Kotova; Camasamudram Vijayasarathy; Emilios K Dimitriadis; Laertis Ikonomou; Howard Jaffe; Paul A Sieving
Journal:  Biochemistry       Date:  2010-08-24       Impact factor: 3.162

Review 2.  X-linked juvenile retinoschisis: clinical diagnosis, genetic analysis, and molecular mechanisms.

Authors:  Robert S Molday; Ulrich Kellner; Bernhard H F Weber
Journal:  Prog Retin Eye Res       Date:  2012-01-03       Impact factor: 21.198

Review 3.  Biology of retinoschisin.

Authors:  Camasamudram Vijayasarathy; Lucia Ziccardi; Paul A Sieving
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

Review 4.  Convergence of Human Genetics and Animal Studies: Gene Therapy for X-Linked Retinoschisis.

Authors:  Ronald A Bush; Lisa L Wei; Paul A Sieving
Journal:  Cold Spring Harb Perspect Med       Date:  2015-06-22       Impact factor: 6.915

5.  Molecular mechanisms leading to null-protein product from retinoschisin (RS1) signal-sequence mutants in X-linked retinoschisis (XLRS) disease.

Authors:  Camasamudram Vijayasarathy; Ruifang Sui; Yong Zeng; Guoxing Yang; Fei Xu; Rafael C Caruso; Richard A Lewis; Lucia Ziccardi; Paul A Sieving
Journal:  Hum Mutat       Date:  2010-11       Impact factor: 4.878

6.  The effects of transient retinal detachment on cavity size and glial and neural remodeling in a mouse model of X-linked retinoschisis.

Authors:  Gabriel Luna; Sten Kjellstrom; Mark R Verardo; Geoffrey P Lewis; Jiyun Byun; Paul A Sieving; Steven K Fisher
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-04-22       Impact factor: 4.799

7.  The Contribution of L-Type Cav1.3 Channels to Retinal Light Responses.

Authors:  Liheng Shi; Janet Ya-An Chang; Fei Yu; Michael L Ko; Gladys Y-P Ko
Journal:  Front Mol Neurosci       Date:  2017-12-05       Impact factor: 5.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.